img

Global Anti-Retroviral Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Anti-Retroviral Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Anti-Retroviral Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Anti-Retroviral Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hepatitis and HIV/AIDS are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Anti-Retroviral Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Anti-Retroviral Drugs key manufacturers include Cardionet, GE Healthcare, Abbott, AstraZeneca, Bristol-Myers-Squibb, Gilead, Cardiac Science Corp., Cardiocom and Biotelemetry, etc. Cardionet, GE Healthcare, Abbott are top 3 players and held % sales share in total in 2022.
Anti-Retroviral Drugs can be divided into Protease Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, Integrase Inhibitors and Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors, etc. Protease Inhibitors is the mainstream product in the market, accounting for % sales share globally in 2022.
Anti-Retroviral Drugs is widely used in various fields, such as Hepatitis, HIV/AIDS, Herpes and Influenza, etc. Hepatitis provides greatest supports to the Anti-Retroviral Drugs industry development. In 2022, global % sales of Anti-Retroviral Drugs went into Hepatitis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Retroviral Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Cardionet
GE Healthcare
Abbott
AstraZeneca
Bristol-Myers-Squibb
Gilead
Cardiac Science Corp.
Cardiocom
Biotelemetry
GlaxoSmithKline
Roche
Segment by Type
Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Integrase Inhibitors
Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors

Segment by Application


Hepatitis
HIV/AIDS
Herpes
Influenza
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Anti-Retroviral Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Anti-Retroviral Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Anti-Retroviral Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Anti-Retroviral Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Anti-Retroviral Drugs introduction, etc. Anti-Retroviral Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Anti-Retroviral Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Anti-Retroviral Drugs Market Overview
1.1 Anti-Retroviral Drugs Product Overview
1.2 Anti-Retroviral Drugs Market Segment by Type
1.2.1 Protease Inhibitors
1.2.2 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Integrase Inhibitors
1.2.4 Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
1.3 Global Anti-Retroviral Drugs Market Size by Type
1.3.1 Global Anti-Retroviral Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Anti-Retroviral Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anti-Retroviral Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Retroviral Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anti-Retroviral Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anti-Retroviral Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anti-Retroviral Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anti-Retroviral Drugs Sales Breakdown by Type (2018-2024)
2 Global Anti-Retroviral Drugs Market Competition by Company
2.1 Global Top Players by Anti-Retroviral Drugs Sales (2018-2024)
2.2 Global Top Players by Anti-Retroviral Drugs Revenue (2018-2024)
2.3 Global Top Players by Anti-Retroviral Drugs Price (2018-2024)
2.4 Global Top Manufacturers Anti-Retroviral Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Retroviral Drugs Market Competitive Situation and Trends
2.5.1 Anti-Retroviral Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Retroviral Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Retroviral Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-Retroviral Drugs Market
2.8 Key Manufacturers Anti-Retroviral Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Retroviral Drugs Status and Outlook by Region
3.1 Global Anti-Retroviral Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anti-Retroviral Drugs Historic Market Size by Region
3.2.1 Global Anti-Retroviral Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Anti-Retroviral Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Anti-Retroviral Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anti-Retroviral Drugs Forecasted Market Size by Region
3.3.1 Global Anti-Retroviral Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Anti-Retroviral Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Anti-Retroviral Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anti-Retroviral Drugs by Application
4.1 Anti-Retroviral Drugs Market Segment by Application
4.1.1 Hepatitis
4.1.2 HIV/AIDS
4.1.3 Herpes
4.1.4 Influenza
4.1.5 Others
4.2 Global Anti-Retroviral Drugs Market Size by Application
4.2.1 Global Anti-Retroviral Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Anti-Retroviral Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anti-Retroviral Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Retroviral Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anti-Retroviral Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anti-Retroviral Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anti-Retroviral Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anti-Retroviral Drugs Sales Breakdown by Application (2018-2024)
5 North America Anti-Retroviral Drugs by Country
5.1 North America Anti-Retroviral Drugs Historic Market Size by Country
5.1.1 North America Anti-Retroviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anti-Retroviral Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Anti-Retroviral Drugs Sales in Value by Country (2018-2024)
5.2 North America Anti-Retroviral Drugs Forecasted Market Size by Country
5.2.1 North America Anti-Retroviral Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Anti-Retroviral Drugs Sales in Value by Country (2024-2034)
6 Europe Anti-Retroviral Drugs by Country
6.1 Europe Anti-Retroviral Drugs Historic Market Size by Country
6.1.1 Europe Anti-Retroviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anti-Retroviral Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Anti-Retroviral Drugs Sales in Value by Country (2018-2024)
6.2 Europe Anti-Retroviral Drugs Forecasted Market Size by Country
6.2.1 Europe Anti-Retroviral Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Anti-Retroviral Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Anti-Retroviral Drugs by Region
7.1 Asia-Pacific Anti-Retroviral Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Retroviral Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anti-Retroviral Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anti-Retroviral Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anti-Retroviral Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Retroviral Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anti-Retroviral Drugs Sales in Value by Region (2024-2034)
8 Latin America Anti-Retroviral Drugs by Country
8.1 Latin America Anti-Retroviral Drugs Historic Market Size by Country
8.1.1 Latin America Anti-Retroviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anti-Retroviral Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anti-Retroviral Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Anti-Retroviral Drugs Forecasted Market Size by Country
8.2.1 Latin America Anti-Retroviral Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anti-Retroviral Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Anti-Retroviral Drugs by Country
9.1 Middle East and Africa Anti-Retroviral Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Retroviral Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anti-Retroviral Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anti-Retroviral Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anti-Retroviral Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Retroviral Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anti-Retroviral Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Cardionet
10.1.1 Cardionet Company Information
10.1.2 Cardionet Introduction and Business Overview
10.1.3 Cardionet Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Cardionet Anti-Retroviral Drugs Products Offered
10.1.5 Cardionet Recent Development
10.2 GE Healthcare
10.2.1 GE Healthcare Company Information
10.2.2 GE Healthcare Introduction and Business Overview
10.2.3 GE Healthcare Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GE Healthcare Anti-Retroviral Drugs Products Offered
10.2.5 GE Healthcare Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Abbott Anti-Retroviral Drugs Products Offered
10.3.5 Abbott Recent Development
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information
10.4.2 AstraZeneca Introduction and Business Overview
10.4.3 AstraZeneca Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 AstraZeneca Anti-Retroviral Drugs Products Offered
10.4.5 AstraZeneca Recent Development
10.5 Bristol-Myers-Squibb
10.5.1 Bristol-Myers-Squibb Company Information
10.5.2 Bristol-Myers-Squibb Introduction and Business Overview
10.5.3 Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers-Squibb Anti-Retroviral Drugs Products Offered
10.5.5 Bristol-Myers-Squibb Recent Development
10.6 Gilead
10.6.1 Gilead Company Information
10.6.2 Gilead Introduction and Business Overview
10.6.3 Gilead Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Gilead Anti-Retroviral Drugs Products Offered
10.6.5 Gilead Recent Development
10.7 Cardiac Science Corp.
10.7.1 Cardiac Science Corp. Company Information
10.7.2 Cardiac Science Corp. Introduction and Business Overview
10.7.3 Cardiac Science Corp. Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cardiac Science Corp. Anti-Retroviral Drugs Products Offered
10.7.5 Cardiac Science Corp. Recent Development
10.8 Cardiocom
10.8.1 Cardiocom Company Information
10.8.2 Cardiocom Introduction and Business Overview
10.8.3 Cardiocom Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Cardiocom Anti-Retroviral Drugs Products Offered
10.8.5 Cardiocom Recent Development
10.9 Biotelemetry
10.9.1 Biotelemetry Company Information
10.9.2 Biotelemetry Introduction and Business Overview
10.9.3 Biotelemetry Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biotelemetry Anti-Retroviral Drugs Products Offered
10.9.5 Biotelemetry Recent Development
10.10 GlaxoSmithKline
10.10.1 GlaxoSmithKline Company Information
10.10.2 GlaxoSmithKline Introduction and Business Overview
10.10.3 GlaxoSmithKline Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 GlaxoSmithKline Anti-Retroviral Drugs Products Offered
10.10.5 GlaxoSmithKline Recent Development
10.11 Roche
10.11.1 Roche Company Information
10.11.2 Roche Introduction and Business Overview
10.11.3 Roche Anti-Retroviral Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Roche Anti-Retroviral Drugs Products Offered
10.11.5 Roche Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Retroviral Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Retroviral Drugs Industrial Chain Analysis
11.4 Anti-Retroviral Drugs Market Dynamics
11.4.1 Anti-Retroviral Drugs Industry Trends
11.4.2 Anti-Retroviral Drugs Market Drivers
11.4.3 Anti-Retroviral Drugs Market Challenges
11.4.4 Anti-Retroviral Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Retroviral Drugs Distributors
12.3 Anti-Retroviral Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Protease Inhibitors
Table 2. Major Company of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 3. Major Company of Integrase Inhibitors
Table 4. Major Company of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Table 5. Global Anti-Retroviral Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Anti-Retroviral Drugs Sales by Type (2018-2024) & (K Pcs)
Table 7. Global Anti-Retroviral Drugs Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Anti-Retroviral Drugs Sales by Type (2018-2024) & (US& Million)
Table 9. Global Anti-Retroviral Drugs Market Share in Value by Type (2018-2024)
Table 10. Global Anti-Retroviral Drugs Price by Type (2018-2024) & (USD/Pcs)
Table 11. Global Anti-Retroviral Drugs Sales by Type (2024-2034) & (K Pcs)
Table 12. Global Anti-Retroviral Drugs Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Anti-Retroviral Drugs Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Anti-Retroviral Drugs Sales Market Share in Value by Type (2024-2034)
Table 15. Global Anti-Retroviral Drugs Price by Type (2024-2034) & (USD/Pcs)
Table 16. North America Anti-Retroviral Drugs Sales by Type (2018-2024) & (K Pcs)
Table 17. North America Anti-Retroviral Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Anti-Retroviral Drugs Sales (K Pcs) by Type (2018-2024)
Table 19. Europe Anti-Retroviral Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Anti-Retroviral Drugs Sales (K Pcs) by Type (2018-2024)
Table 21. Asia-Pacific Anti-Retroviral Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Anti-Retroviral Drugs Sales (K Pcs) by Type (2018-2024)
Table 23. Latin America Anti-Retroviral Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Anti-Retroviral Drugs Sales (K Pcs) by Type (2018-2024)
Table 25. Middle East and Africa Anti-Retroviral Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Anti-Retroviral Drugs Sales by Company (2018-2024) & (K Pcs)
Table 27. Global Anti-Retroviral Drugs Sales Share by Company (2018-2024)
Table 28. Global Anti-Retroviral Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Anti-Retroviral Drugs Revenue Share by Company (2018-2024)
Table 30. Global Market Anti-Retroviral Drugs Price by Company (2018-2024) & (USD/Pcs)
Table 31. Global Anti-Retroviral Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Anti-Retroviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Retroviral Drugs as of 2022)
Table 34. Date of Key Manufacturers Enter into Anti-Retroviral Drugs Market
Table 35. Key Manufacturers Anti-Retroviral Drugs Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Anti-Retroviral Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Anti-Retroviral Drugs Sales by Region (2018-2024) & (K Pcs)
Table 39. Global Anti-Retroviral Drugs Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Anti-Retroviral Drugs Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Anti-Retroviral Drugs Sales Market Share in Value by Region (2018-2024)
Table 42. Global Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 43. Global Anti-Retroviral Drugs Sales by Region (2024-2034) & (K Pcs)
Table 44. Global Anti-Retroviral Drugs Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Anti-Retroviral Drugs Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Anti-Retroviral Drugs Sales Market Share in Value by Region (2024-2034)
Table 47. Global Anti-Retroviral Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 48. Global Anti-Retroviral Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Anti-Retroviral Drugs Sales by Application (2018-2024) & (K Pcs)
Table 50. Global Anti-Retroviral Drugs Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Anti-Retroviral Drugs Sales Market Share in Value by Application (2018-2024)
Table 53. Global Anti-Retroviral Drugs Price by Application (2018-2024) & (USD/Pcs)
Table 54. Global Anti-Retroviral Drugs Sales by Application (2024-2034) & (K Pcs)
Table 55. Global Anti-Retroviral Drugs Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Anti-Retroviral Drugs Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Anti-Retroviral Drugs Sales Market Share in Value by Application (2024-2034)
Table 58. Global Anti-Retroviral Drugs Price by Application (2024-2034) & (USD/Pcs)
Table 59. North America Anti-Retroviral Drugs Sales by Application (2018-2024) (K Pcs)
Table 60. North America Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Anti-Retroviral Drugs Sales by Application (2018-2024) (K Pcs)
Table 62. Europe Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Anti-Retroviral Drugs Sales by Application (2018-2024) (K Pcs)
Table 64. Asia-Pacific Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Anti-Retroviral Drugs Sales by Application (2018-2024) (K Pcs)
Table 66. Latin America Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2018-2024) (K Pcs)
Table 68. Middle East and Africa Anti-Retroviral Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Anti-Retroviral Drugs Sales by Country (2018-2024) & (K Pcs)
Table 70. North America Anti-Retroviral Drugs Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Anti-Retroviral Drugs Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Anti-Retroviral Drugs Sales Market Share in Value by Country (2018-2024)
Table 73. North America Anti-Retroviral Drugs Sales by Country (2024-2034) & (K Pcs)
Table 74. North America Anti-Retroviral Drugs Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Anti-Retroviral Drugs Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Anti-Retroviral Drugs Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Anti-Retroviral Drugs Sales by Country (2018-2024) & (K Pcs)
Table 78. Europe Anti-Retroviral Drugs Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Anti-Retroviral Drugs Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Anti-Retroviral Drugs Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Anti-Retroviral Drugs Sales by Country (2024-2034) & (K Pcs)
Table 82. Europe Anti-Retroviral Drugs Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Anti-Retroviral Drugs Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Anti-Retroviral Drugs Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Anti-Retroviral Drugs Sales by Region (2018-2024) & (K Pcs)
Table 86. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Anti-Retroviral Drugs Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Anti-Retroviral Drugs Sales by Region (2024-2034) & (K Pcs)
Table 90. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Anti-Retroviral Drugs Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Anti-Retroviral Drugs Sales by Country (2018-2024) & (K Pcs)
Table 94. Latin America Anti-Retroviral Drugs Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Anti-Retroviral Drugs Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Anti-Retroviral Drugs Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Anti-Retroviral Drugs Sales by Country (2024-2034) & (K Pcs)
Table 98. Latin America Anti-Retroviral Drugs Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Anti-Retroviral Drugs Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Anti-Retroviral Drugs Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2018-2024) & (K Pcs)
Table 102. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2024-2034) & (K Pcs)
Table 106. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Anti-Retroviral Drugs Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Value by Country (2024-2034)
Table 109. Cardionet Company Information
Table 110. Cardionet Introduction and Business Overview
Table 111. Cardionet Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 112. Cardionet Anti-Retroviral Drugs Product
Table 113. Cardionet Recent Development
Table 114. GE Healthcare Company Information
Table 115. GE Healthcare Introduction and Business Overview
Table 116. GE Healthcare Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 117. GE Healthcare Anti-Retroviral Drugs Product
Table 118. GE Healthcare Recent Development
Table 119. Abbott Company Information
Table 120. Abbott Introduction and Business Overview
Table 121. Abbott Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Abbott Anti-Retroviral Drugs Product
Table 123. Abbott Recent Development
Table 124. AstraZeneca Company Information
Table 125. AstraZeneca Introduction and Business Overview
Table 126. AstraZeneca Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 127. AstraZeneca Anti-Retroviral Drugs Product
Table 128. AstraZeneca Recent Development
Table 129. Bristol-Myers-Squibb Company Information
Table 130. Bristol-Myers-Squibb Introduction and Business Overview
Table 131. Bristol-Myers-Squibb Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 132. Bristol-Myers-Squibb Anti-Retroviral Drugs Product
Table 133. Bristol-Myers-Squibb Recent Development
Table 134. Gilead Company Information
Table 135. Gilead Introduction and Business Overview
Table 136. Gilead Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 137. Gilead Anti-Retroviral Drugs Product
Table 138. Gilead Recent Development
Table 139. Cardiac Science Corp. Company Information
Table 140. Cardiac Science Corp. Introduction and Business Overview
Table 141. Cardiac Science Corp. Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 142. Cardiac Science Corp. Anti-Retroviral Drugs Product
Table 143. Cardiac Science Corp. Recent Development
Table 144. Cardiocom Company Information
Table 145. Cardiocom Introduction and Business Overview
Table 146. Cardiocom Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 147. Cardiocom Anti-Retroviral Drugs Product
Table 148. Cardiocom Recent Development
Table 149. Biotelemetry Company Information
Table 150. Biotelemetry Introduction and Business Overview
Table 151. Biotelemetry Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Biotelemetry Anti-Retroviral Drugs Product
Table 153. Biotelemetry Recent Development
Table 154. GlaxoSmithKline Company Information
Table 155. GlaxoSmithKline Introduction and Business Overview
Table 156. GlaxoSmithKline Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 157. GlaxoSmithKline Anti-Retroviral Drugs Product
Table 158. GlaxoSmithKline Recent Development
Table 159. Roche Company Information
Table 160. Roche Introduction and Business Overview
Table 161. Roche Anti-Retroviral Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 162. Roche Anti-Retroviral Drugs Product
Table 163. Roche Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. Anti-Retroviral Drugs Market Trends
Table 167. Anti-Retroviral Drugs Market Drivers
Table 168. Anti-Retroviral Drugs Market Challenges
Table 169. Anti-Retroviral Drugs Market Restraints
Table 170. Anti-Retroviral Drugs Distributors List
Table 171. Anti-Retroviral Drugs Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Retroviral Drugs Product Picture
Figure 2. Global Anti-Retroviral Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anti-Retroviral Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anti-Retroviral Drugs Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of Protease Inhibitors
Figure 6. Global Protease Inhibitors Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 8. Global Non-Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Integrase Inhibitors
Figure 10. Global Integrase Inhibitors Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
Figure 12. Global Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Global Anti-Retroviral Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Anti-Retroviral Drugs Sales Market Share by Type in 2022 & 2034
Figure 15. North America Anti-Retroviral Drugs Sales Market Share in Volume by Type in 2022
Figure 16. North America Anti-Retroviral Drugs Sales Market Share in Value by Type in 2022
Figure 17. Europe Anti-Retroviral Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Europe Anti-Retroviral Drugs Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Value by Type in 2022
Figure 21. Latin America Anti-Retroviral Drugs Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Anti-Retroviral Drugs Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Retroviral Drugs Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-Retroviral Drugs Revenue in 2022
Figure 27. Anti-Retroviral Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hepatitis
Figure 29. Global Hepatitis Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of HIV/AIDS
Figure 31. Global HIV/AIDS Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Herpes
Figure 33. Global Herpes Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Influenza
Figure 35. Global Influenza Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Global Anti-Retroviral Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Anti-Retroviral Drugs Sales Market Share by Application in 2022 & 2034
Figure 40. North America Anti-Retroviral Drugs Sales Market Share in Volume by Application in 2022
Figure 41. North America Anti-Retroviral Drugs Sales Market Share in Value by Application in 2022
Figure 42. Europe Anti-Retroviral Drugs Sales Market Share in Volume by Application in 2022
Figure 43. Europe Anti-Retroviral Drugs Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Anti-Retroviral Drugs Sales Market Share in Value by Application in 2022
Figure 46. Latin America Anti-Retroviral Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Anti-Retroviral Drugs Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Anti-Retroviral Drugs Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Anti-Retroviral Drugs Manufacturing Cost Structure
Figure 51. Anti-Retroviral Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries